CureVac and GSK to receive money and royalties from BioNTech/Pfizer as part of mRNA patent settlement
Article Title: CureVac and GSK to receive money and royalties from BioNTech/Pfizer as part of mRNA patent settlement Publication Date: Aug 08, 2025 According to a recent article, BioNTech/Pfizer has reached a significant settlement in a three-year long mRNA patent…